OpenURL Connection Search

Select item for more details and to access through your institution.

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
Published in:
2021
By:
- Veitch, Zachary W;
- Shepshelovich, Daniel;
- Gallagher, Christina;
- Wang, Lisa;
- Razak, Albiruni R Abdul;
- Spreafico, Anna;
- Bedard, Philippe L;
- Siu, Lillian L;
- Minasian, Lori;
- Hansen, Aaron R;
- Abdul Razak, Albiruni R
Publication type:
journal article
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24677-6
By:
- Anderson, Nathaniel D.;
- Babichev, Yael;
- Fuligni, Fabio;
- Comitani, Federico;
- Layeghifard, Mehdi;
- Venier, Rosemarie E.;
- Dentro, Stefan C.;
- Maheshwari, Anant;
- Guram, Sheena;
- Wunker, Claire;
- Thompson, J. Drew;
- Yuki, Kyoko E.;
- Hou, Huayun;
- Zatzman, Matthew;
- Light, Nicholas;
- Bernardini, Marcus Q.;
- Wunder, Jay S.;
- Andrulis, Irene L.;
- Ferguson, Peter;
- Razak, Albiruni R. Abdul
Publication type:
Article
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Published in:
Rare Tumors, 2022, p. 1, doi. 10.1177/20363613221100033
By:
- Van Tine, Brian A;
- Krarup-Hansen, Anders;
- Hess, Lisa M;
- Abdul Razak, Albiruni R;
- Soldatenkova, Victoria;
- Wright, Jennifer;
- Park, Se Hoon
Publication type:
Article
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial.
Published in:
Rare Tumors, 2022, v. 14, p. 1, doi. 10.1177/20363613221100033
By:
- Van Tine, Brian A.;
- Krarup-Hansen, Anders;
- Hess, Lisa M.;
- Razak, Albiruni R. Abdul;
- Soldatenkova, Victoria;
- Wright, Jennifer;
- Se Hoon Park
Publication type:
Article
Early phase oncology clinical trials in Malaysia: current status and future perspectives.
Published in:
Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 3, p. 296, doi. 10.1111/ajco.13886
By:
- Voon, Pei‐Jye;
- Lai, Wei‐Hong;
- Bustaman, Ros Suzanna;
- Siu, Lillian L.;
- Razak, Albiruni R. Abdul;
- Yusof, Akhmal;
- Abdullah, Noor Hisham
Publication type:
Article
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2020, v. 38, n. 4, p. 1156, doi. 10.1007/s10637-019-00869-2
By:
- Abdul Razak, Albiruni R.;
- Miller, Wilson H.;
- Uy, Geoffrey L.;
- Blotner, Steven;
- Young, Anne-Marie;
- Higgins, Brian;
- Chen, Lin-Chi;
- Gore, Lia
Publication type:
Article
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.
Published in:
2016
By:
- Angarita, Fernando A.;
- Cannell, Amanda J.;
- Abdul Razak, Albiruni R.;
- Dickson, Brendan C.;
- Blackstein, Martin E.
Publication type:
journal article
High prevalence of persistent emotional distress in desmoid tumor.
Published in:
2020
By:
- Ingley, Katrina M.;
- Klein, Roberta;
- Theobalds, Nicole;
- Burtenshaw, Sally;
- Abdul Razak, Albiruni R.;
- Chen, Bo;
- Xu, Wei;
- Gladdy, Rebecca;
- Li, Madeline;
- Gupta, Abha A.
Publication type:
journal article
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index.
Published in:
JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz071
By:
- Day, Daphne;
- Guo, Christina;
- Kanjanapan, Yada;
- Tran, Ben;
- Spreafico, Anna;
- Joshua, Anthony M;
- Wang, Lisa;
- Razak, Albiruni R Abdul;
- Leighl, Natasha B;
- Hansen, Aaron R;
- Butler, Marcus O;
- Siu, Lillian L;
- Desai, Jayesh;
- Bedard, Philippe L
Publication type:
Article
Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program.
Published in:
Cancer Medicine, 2020, v. 9, n. 24, p. 9282, doi. 10.1002/cam4.3531
By:
- Veitch, Zachary W.;
- Fasih, Samir;
- Griffin, Anthony M.;
- Al‐Ezzi, Esmail M.;
- Gupta, Abha A.;
- Ferguson, Peter C.;
- Wunder, Jay S.;
- Abdul Razak, Albiruni R.
Publication type:
Article
Cancer patients' experiences with immune checkpoint modulators: A qualitative study.
Published in:
Cancer Medicine, 2020, v. 9, n. 9, p. 3015, doi. 10.1002/cam4.2940
By:
- Ala‐Leppilampi, Kari;
- Baker, Natalie A.;
- McKillop, Chris;
- Butler, Marcus O.;
- Siu, Lillian L.;
- Spreafico, Anna;
- Abdul Razak, Albiruni R.;
- Joshua, Anthony M.;
- Hogg, David;
- Bedard, Philippe L.;
- Leighl, Natasha;
- Oza, Amit M.;
- Parsons, Janet A.;
- Hansen, Aaron R.
Publication type:
Article
Primary cardiac sarcomas: A multi‐national retrospective review.
Published in:
Cancer Medicine, 2019, v. 8, n. 1, p. 104, doi. 10.1002/cam4.1897
By:
- Chen, Tom Wei‐Wu;
- Loong, Herbert H.;
- Srikanthan, Amirrtha;
- Zer, Alona;
- Barua, Reeta;
- Butany, Jagdish;
- Cusimano, Robert J.;
- Liang, Yun‐Chieh;
- Chang, Chin‐Hao;
- Iakobishvili, Zaza;
- Razak, Albiruni R. Abdul;
- Lewin, Jeremy
Publication type:
Article
A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS).
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43222-6
By:
- Veitch, Zachary;
- Zer, Alona;
- Loong, Herbert;
- Salah, Samer;
- Masood, Maryam;
- Gupta, Abha;
- Bradbury, Penelope A.;
- Hogg, David;
- Wong, Andrew;
- Kandel, Rita;
- Charames, George S.;
- Abdul Razak, Albiruni R.
Publication type:
Article
Canadian consensus on TRK‐inhibitor therapy for NTRK fusion‐positive sarcoma.
Published in:
International Journal of Cancer, 2021, v. 149, n. 9, p. 1691, doi. 10.1002/ijc.33723
By:
- Simmons, Christine;
- Deyell, Rebecca J.;
- MacNeill, Andrea J.;
- Vera‐Badillo, Francisco E.;
- Smrke, Alannah;
- Abdul Razak, Albiruni R.;
- Banerji, Shantanu;
- McLeod, Deanna;
- Noujaim, Jonathan
Publication type:
Article
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.
Published in:
2018
By:
- Zer, Alona;
- Pond, Gregory R.;
- Razak, Albiruni R. Abdul;
- Tirona, Kattleya;
- Gan, Hui K.;
- Chen, Eric X.;
- O’Sullivan, Brian;
- Waldron, John;
- Goldstein, David P.;
- Weinreb, Ilan;
- Hope, Andrew J.;
- Kim, John J.;
- Chan, Kelvin K. W.;
- Chan, Andrew K.;
- Siu, Lillian L.;
- Bernstein, Lori J.;
- O'Sullivan, Brian
Publication type:
journal article
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00415
By:
- Gadalla, Ramy;
- Noamani, Babak;
- MacLeod, Bethany L.;
- Dickson, Russell J.;
- Guo, Mengdi;
- Xu, Wenxi;
- Lukhele, Sabelo;
- Elsaesser, Heidi J.;
- Razak, Albiruni R. Abdul;
- Hirano, Naoto;
- McGaha, Tracy L.;
- Wang, Ben;
- Butler, Marcus;
- Guidos, Cynthia J.;
- Ohashi, Pam S.;
- Siu, Lillian L.;
- Brooks, David G.
Publication type:
Article
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Published in:
2020
By:
- Tap, William D.;
- Wagner, Andrew J.;
- Schöffski, Patrick;
- Martin-Broto, Javier;
- Krarup-Hansen, Anders;
- Ganjoo, Kristen N.;
- Yen, Chueh-Chuan;
- Abdul Razak, Albiruni R.;
- Spira, Alexander;
- Kawai, Akira;
- Le Cesne, Axel;
- Van Tine, Brian A.;
- Naito, Yoichi;
- Park, Se Hoon;
- Fedenko, Alexander;
- Pápai, Zsuzsanna;
- Soldatenkova, Victoria;
- Shahir, Ashwin;
- Mo, Gary;
- Wright, Jennifer
Publication type:
journal article
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
Published in:
British Journal of Cancer, 2023, v. 129, n. 4, p. 612, doi. 10.1038/s41416-023-02307-w
By:
- Janse van Rensburg, Helena J.;
- Liu, Zhihui;
- Watson, Geoffrey A.;
- Veitch, Zachary W.;
- Shepshelovich, Daniel;
- Spreafico, Anna;
- Abdul Razak, Albiruni R.;
- Bedard, Philippe L.;
- Siu, Lillian L.;
- Minasian, Lori;
- Hansen, Aaron R.
Publication type:
Article
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Published in:
British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0
By:
- El-Khoueiry, Anthony B.;
- Clarke, James;
- Neff, Tobias;
- Crossman, Tim;
- Ratia, Nirav;
- Rathi, Chetan;
- Noto, Paul;
- Tarkar, Aarti;
- Garrido-Laguna, Ignacio;
- Calvo, Emiliano;
- Rodón, Jordi;
- Tran, Ben;
- O'Dwyer, Peter J.;
- Cuker, Adam;
- Abdul Razak, Albiruni R.
Publication type:
Article
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Published in:
2023
By:
- Curigliano, Giuseppe;
- Shapiro, Geoffrey I.;
- Kristeleit, Rebecca S.;
- Abdul Razak, Albiruni R.;
- Leong, Stephen;
- Alsina, Maria;
- Giordano, Antonio;
- Gelmon, Karen A.;
- Stringer-Reasor, Erica;
- Vaishampayan, Ulka N.;
- Middleton, Mark;
- Olszanski, Anthony J.;
- Rugo, Hope S.;
- Kern, Kenneth A.;
- Pathan, Nuzhat;
- Perea, Rachelle;
- Pierce, Kristen J.;
- Mutka, Sarah C.;
- Wainberg, Zev A.
Publication type:
Correction Notice
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Published in:
2023
By:
- Curigliano, Giuseppe;
- Shapiro, Geoffrey I.;
- Kristeleit, Rebecca S.;
- Abdul Razak, Albiruni R.;
- Leong, Stephen;
- Alsina, Maria;
- Giordano, Antonio;
- Gelmon, Karen A.;
- Stringer-Reasor, Erica;
- Vaishampayan, Ulka N.;
- Middleton, Mark;
- Olszanski, Anthony J.;
- Rugo, Hope S.;
- Kern, Kenneth A.;
- Pathan, Nuzhat;
- Perea, Rachelle;
- Pierce, Kristen J.;
- Mutka, Sarah C.;
- Wainberg, Zev A.
Publication type:
journal article
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
Published in:
2022
By:
- Watson, Geoffrey A.;
- Veitch, Zachary W.;
- Shepshelovich, Daniel;
- Liu, Zhihui Amy;
- Spreafico, Anna;
- Abdul Razak, Albiruni R.;
- Bedard, Philippe L.;
- Siu, Lillian L.;
- Minasian, Lori;
- Hansen, Aaron R.
Publication type:
journal article
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export.
Published in:
Clinical Pharmacokinetics, 2021, v. 60, n. 8, p. 957, doi. 10.1007/s40262-021-01016-y
By:
- Bader, Justin C.;
- Abdul Razak, Albiruni R.;
- Shacham, Sharon;
- Xu, Hongmei
Publication type:
Article
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT).
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02851-6
By:
- Genta, Sofia;
- Lajkosz, Katherine;
- Yee, Noelle R.;
- Spiliopoulou, Pavlina;
- Heirali, Alya;
- Hansen, Aaron R.;
- Siu, Lillian L.;
- Saibil, Sam;
- Stayner, Lee-Anne;
- Yanekina, Maryia;
- Sauder, Maxwell B.;
- Keshavarzi, Sareh;
- Salawu, Abdulazeez;
- Vornicova, Olga;
- Butler, Marcus O.;
- Bedard, Philippe L.;
- Razak, Albiruni R. Abdul;
- Rottapel, Robert;
- Chruscinski, Andrzej;
- Coburn, Bryan
Publication type:
Article
Pretreatment neurocognitive function and self‐reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
Published in:
Head & Neck, 2018, v. 40, n. 9, p. 2029, doi. 10.1002/hed.25198
By:
- Bernstein, Lori J.;
- Tirona, Kattleya;
- Pond, Gregory R.;
- Gan, Hui K.;
- Chan, Kelvin K.;
- Chen, Eric X.;
- Siu, Lillian L.;
- Razak, Albiruni R. Abdul;
- Hope, Andrew;
- Kim, John
Publication type:
Article
Survival outcomes for cutaneous angiosarcoma of the scalp versus face.
Published in:
Head & Neck, 2017, v. 39, n. 6, p. 1205, doi. 10.1002/hed.24747
By:
- Bernstein, Jonathan M.;
- Irish, Jonathan C.;
- Brown, Dale H.;
- Goldstein, David;
- Chung, Peter;
- Razak, Albiruni R. Abdul;
- Catton, Charles;
- Gilbert, Ralph W.;
- Gullane, Patrick J.;
- O'Sullivan, Brian
Publication type:
Article
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.
Published in:
Targeted Oncology, 2024, v. 19, n. 5, p. 711, doi. 10.1007/s11523-024-01076-7
By:
- Salawu, Abdulazeez;
- Malone, Eoghan R.;
- Al-Ezzi, Esmail;
- Genta, Sofia;
- Vornicova, Olga;
- Wang, Lisa;
- Arones, Limore;
- Phillips, Madeline;
- Lee, Jasmine;
- Watson, Geoffrey A.;
- Gupta, Abha A.;
- Abdul Razak, Albiruni R.
Publication type:
Article
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Published in:
Targeted Oncology, 2023, v. 18, n. 6, p. 853, doi. 10.1007/s11523-023-00997-z
By:
- Razak, Albiruni R. Abdul;
- Wang, Hung-Ming;
- Chang, Jang-Yang;
- Ahn, Myung-Ju;
- Munster, Pamela;
- Blumenschein Jr, George;
- Solomon, Benjamin;
- Lim, Darren Wan-Teck;
- Hong, Ruey-Long;
- Pfister, David;
- Saba, Nabil F.;
- Lee, Se-Hoon;
- van Herpen, Carla;
- Quadt, Cornelia;
- Bootle, Douglas;
- Blumenstein, Lars;
- Demanse, David;
- Delord, Jean-Pierre
Publication type:
Article
Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
Published in:
2022
By:
- Udayakumar, Suji;
- Thomson, Sasha;
- Razak, Albiruni R. Abdul;
- Chan, Kelvin K. W.
Publication type:
journal article
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Published in:
Targeted Oncology, 2022, v. 17, n. 3, p. 271, doi. 10.1007/s11523-022-00884-z
By:
- Salawu, Abdulazeez;
- Hansen, Aaron R.;
- Spreafico, Anna;
- Al-Ezzi, Esmail;
- Webster, Sheila;
- Bedard, Philippe L.;
- Doi, Jeffrey;
- Wang, Lisa;
- Siu, Lillian L.;
- Abdul Razak, Albiruni R.
Publication type:
Article
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies.
Published in:
2019
By:
- de Jonge, Maja J. A.;
- Steeghs, Neeltje;
- Lolkema, Martijn P.;
- Hotte, Sebastien J.;
- Hirte, Hal W.;
- van der Biessen, Diane A. J.;
- Abdul Razak, Albiruni R.;
- De Vos, Filip Y. F. L.;
- Verheijen, Remy B.;
- Schnell, David;
- Pronk, Linda C.;
- Jansen, Monique;
- Siu, Lillian L.
Publication type:
journal article
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Published in:
2020
By:
- Hansen, Aaron R.;
- Ala‐Leppilampi, Kari;
- McKillop, Chris;
- Siu, Lillian L.;
- Bedard, Philippe L.;
- Abdul Razak, Albiruni R.;
- Spreafico, Anna;
- Sridhar, Srikala S.;
- Leighl, Natasha;
- Butler, Marcus O.;
- Hogg, David;
- Sacher, Adrian;
- Oza, Amit M.;
- Al‐Agha, Rany;
- Maurice, Catherine;
- Chan, Christopher T.;
- Shapera, Shane;
- Feld, Jordan J.;
- Nisenbaum, Rosane;
- Webster, Kimberly
Publication type:
journal article
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
Published in:
PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189848
By:
- O’Neil, Bert H.;
- Wallmark, John M.;
- Lorente, David;
- Elez, Elena;
- Raimbourg, Judith;
- Gomez-Roca, Carlos;
- Ejadi, Samuel;
- Piha-Paul, Sarina A.;
- Stein, Mark N.;
- Abdul Razak, Albiruni R.;
- Dotti, Katia;
- Santoro, Armando;
- Cohen, Roger B.;
- Gould, Marlena;
- Saraf, Sanatan;
- Stein, Karen;
- Han, Sae-Won
Publication type:
Article
Early phase clinical trials to identify optimal dosing and safety.
Published in:
Molecular Oncology, 2015, v. 9, n. 5, p. 997, doi. 10.1016/j.molonc.2014.07.025
By:
- Cook, Natalie;
- Hansen, Aaron R.;
- Siu, Lillian L.;
- Abdul Razak, Albiruni R.
Publication type:
Article

Found: 34